PRGO News and Press, Perrigo Company plc From 01/25/19

Non-profit Civica Rx, formed by a consortium of hospital groups, expects to be able to offer about 20 generic medicines this year aimed aimed at preventing shortages and sidestepping price hikes. Most have been on the market for many decades. It forecasts that its lineup will expand to ~10...

The Stock Exchange is all about trading. Each week we do the following: discuss an important issue for traders; highlight several technical trading methods, including current ideas; feature advice from top traders and writers; and provide a few (minority) reactions from fundamental...

NEW YORK, Jan. 23, 2019 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Perrigo Company plc ("Perrigo" or the "Company")(NYSE:PRGO) of the March 4, 2019 deadline to seek the role of lead plaintiff in a federal securities class actio...

Coming off his worst year ever, Greenlight Capital's David Einhorn has informed investors that he has rejiggered his portfolio and will reopen his funds to new investments, saying that "we no longer believe there is risk of our assets growing too quickly" (from cash inflows versus apprecia...

Stocks in News: FPRX, ECYT Five Prime launches late-stage study of bemarituzumab + chemo in gastric cancer or GEJ Discussion : Five Prime Therapeutics' ( FPRX ) FPA144 (bemarituzumab) plus chemotherapy completed Part 1 of a Phase 1/3 clinical trial evaluating treatment-naive patients ...

In a move that would make Martin Shkreli proud, privately held Nostrum Laboratories has increased the price of antibiotic nitrofurantoin, on the market since 1953 to treat bladder infections, 400%. A bottle of the pills now costs $2,393, up from ~$475. More news on: Amneal Pharmaceutical...

The Senate will vote next week on the Opioid Crisis Response Act, a lineup of over 70 proposals to fight the opioid crisis following the 50 opioid-related bills that passed the House in June. More news on: Endo International plc, Mallinckrodt PLC, INDIVIOR PLC ADR, Healthcare stocks news...

DUBLIN , Sept. 7, 2018 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) today announced that it has received final approval from the U.S. Food & Drug administration for the store brand over-the-counter (OTC) equivalent of Imodium ® Multi-Symptom Relief (loperamide h...

This article is part of a series that provides an ongoing analysis of the changes made to David Einhorn's Greenlight Capital 13F portfolio on a quarterly basis. It is based on Einhorn's regulatory 13F Form filed on 08/14/2018. Please visit our Tracking David Einhorn's Greenlight Capital Hol...